About Ombre
Ombre is a company based in San Francisco (United States) founded in 2016. Ombre has raised $5.3 million across 5 funding rounds from investors including Plug and Play Tech Center, Pivot North Capital and TMV. Ombre offers products and services including Gut Health Test, Rise Prebiotic, Prebiotic Fiber With Super Greens, 3-in-1 Probiotic+, and Healthy Gut. Ombre operates in a competitive market with competitors including Viome, Flore, Elo Health, Baze and Rootine, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantbiome, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.3 M (USD)
in 5 rounds
-
Latest Funding Round
$3 M (USD), Seed
Nov 01, 2021
-
Investors
Plug and Play Tech Center
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ombre
Ombre offers a comprehensive portfolio of products and services, including Gut Health Test, Rise Prebiotic, Prebiotic Fiber With Super Greens, 3-in-1 Probiotic+, and Healthy Gut.
Analyzes gut bacteria for personalized health recommendations
Boosts beneficial bacteria to improve digestion and gut health
Reduces bloating and supports immunity with organic ingredients
Enhances digestion and bowel regularity with prebiotic blend
Supports immune system and reduces digestive discomfort
Aids weight management and metabolic wellness
Boosts mental and physical performance with probiotics
Strengthens immunity against inflammation and disease
People of Ombre
Unlock access to complete
Unlock access to complete
Funding Insights of Ombre
Ombre has successfully raised a total of $5.3M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ombre
Ombre has secured backing from 10 investors, including venture fund investors. Prominent investors backing the company include Plug and Play Tech Center, Pivot North Capital and TMV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pivot North Capital is involved in capital investment activities.
|
Locked | Locked | Locked | |
|
TMV is engaged in venture capital investments for transformative startups.
|
Locked | Locked | Locked | |
|
VC firm investing primarily in China, the US and Israel
|
Locked | Locked | Locked |
Investor details for Ombre
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ombre
Investment portfolio details for Ombre
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ombre
Detailed financials for Ombre
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ombre Comparisons
Peer comparison for Ombre
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ombre
Ombre operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Flore, Elo Health, Baze and Rootine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Customized probiotics for gut health are provided via stool analysis.
|
|
| Locked | Locked | Locked |
Personalized supplements are delivered based on biochemical analysis.
|
|
| Locked | Locked | Locked |
Personalized vitamin supplements are provided based on biochemical tests.
|
|
| Locked | Locked | Locked |
Provider of personalized nutrition supplements
|
Detailed competitors of Ombre
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ombre
Complete news archive for Ombre
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ombre
Ombre was founded in 2016.
Ombre is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ombre is a funded company, having raised a total of $5.3M across 5 funding rounds to date.
Ombre was founded in 2016 in San Francisco, United States, and operates in the health and wellness sector focused on microbiome analysis. Test kits are provided to assess users gut microbiomes, enabling the delivery of strain-specific probiotic supplements through subscription services. Operations center on personalized nutrition solutions derived from microbiome data, with distribution handled primarily in the U.S. market.
Ombre's top competitors include Viome, Flore and Elo Health.
Ombre offers Gut Health Test, Rise Prebiotic, Prebiotic Fiber With Super Greens, 3-in-1 Probiotic+, and 4 more products and services.
Ombre has 10 investors. Key investors include Plug and Play Tech Center, Pivot North Capital, TMV, Shanda, and Unilever Ventures.